For Immediate Release
ST. GEORGE, UT — July 29, 2026 — Stuck on a GLP-1 weight loss plateau? Dr. Daren Brooks explains why plateaus happen on Ozempic, Wegovy, or Mounjaro — and the medically supervised strategies that break through them.
Weight loss from GLP-1 therapies follows a predictable curve: rapid early loss followed by a plateau, typically between weeks 12 and 24. Appetite resets at a lower level, resting metabolic rate decreases, muscle mass may decline without adequate protein and resistance exercise, and dose ceiling effects emerge at a stable titration level.
Metabolic adaptation is the most powerful force working against continued weight loss. When you lose weight rapidly, your body reduces thyroid output, lowers leptin, and increases ghrelin — dropping total daily energy expenditure by 200–400 calories below what your new weight would predict.
Elevated cortisol promotes fat storage and counteracts GLP-1's benefits. Sleep restriction reduces fat loss by 55% even with the same caloric deficit.
Prioritize 1.2–1.6 g/kg of body weight in protein daily. Recalibrate total caloric intake to reflect your new, lighter body.
“Recovery is possible with the right, evidence-based support — that is the work we do every day at The Bridge.” — Dr. Daren Brooks, D.O., Founder & CEO, The Bridge Health Recovery Center
Read the full guide: Hit a GLP-1 Weight Loss Plateau? Why It Happens and What Actually Helps.
Author: Dr. Daren Brooks, D.O., Founder & CEO, The Bridge Health Recovery Center